Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MTI Interim / Quarterly Report 2021

Nov 16, 2021

52003_rns_2021-11-16_2080e6f3-671e-44ee-888f-7de3da6920fa.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

1

==> picture [680 x 70] intentionally omitted <==

2021 Investment Forum

Date: November 16, 2021

==> picture [720 x 5] intentionally omitted <==

Disclaimer

==> picture [53 x 54] intentionally omitted <==

==> picture [46 x 21] intentionally omitted <==

----- Start of picture text ----- 2----- End of picture text -----

• The information contained in this presentation, including all forward-looking statements, is subject to change without notice, whether as a result of new information, future events or otherwise, and Microelectronics Technology Inc. ( the “Company”) undertakes no obligation to update or revise the information contained in this presentation.

  • Investors are cautioned not to place under reliance on these forward-looking statements, which are made as of the date of this presentation, and we assume no obligation to update or revise any forward-looking statement.

==> picture [720 x 5] intentionally omitted <==

MTI CONFIDENTIAL

Agenda

==> picture [53 x 54] intentionally omitted <==

==> picture [46 x 21] intentionally omitted <==

----- Start of picture text ----- 3----- End of picture text -----

  • Welcome & Opening Remark

  • 2021 Q3 Financial Highlights

    • Taishin Securities Hualin Chi
  • Market Status & Business Strategy Eugene Wu

  • Q&A

==> picture [720 x 5] intentionally omitted <==

MTI CONFIDENTIAL

==> picture [207 x 96] intentionally omitted <==

2021 Q3 Financial Highlights

==> picture [90 x 91] intentionally omitted <==

Consolidated Income Statement

==> picture [53 x 54] intentionally omitted <==

5

(in NT$M) 2021Q3 YTD % of Rev 2020Q3 YTD % of Rev YoY(%)
Revenue 3,006 100 2,946 100 2
Grossprofit 428 14 567 19 (25)
Operating expense 742 25 649 22 14
R&D 530 18 444 15 19
S&M 106 4 106 4 0
G&A 100 3 99 3 1
Expected Credit G/L 6 0 0 0 0
Operating income (314) (10) (82) (3)
Non-operatingincome 6 0 41 2
Net income (308) (10) (54) (1)
Basic EPS(in NT$) (1.35) (0.24)

==> picture [720 x 5] intentionally omitted <==

MTI CONFIDENTIAL

Sales analysis by product

==> picture [53 x 54] intentionally omitted <==

6

==> picture [333 x 289] intentionally omitted <==

==> picture [329 x 289] intentionally omitted <==

==> picture [720 x 5] intentionally omitted <==

MTI CONFIDENTIAL

7

Consolidated Balance Sheet

==> picture [53 x 54] intentionally omitted <==

(in NT$M) Sep 30 2021 Sep 30 2021 Dec 31 2020 Dec 31 2020 Sep 30 2020 Sep 30 2020
AMT % AMT % AMT %
Cash and cash equivalent 1,117 18 1,325 25 1,169 24
Accounts receivable 1,133 18 973 18 918 18
Inventory 1,948 31 1,008 19 1,046 21
Current assets 4,337 69 3,451 64 3,287 66
Total assets 6,327 100 5,400 100 4,967 100
Short term loan 943 15 368 7 325 7
Accountspayable 1,369 22 856 16 758 15
Current liability 2,882 46 1,889 35 1,575 32
Longterm loan 669 11 339 6 374 8
Non-current liability 1,355 21 1,092 20 892 18
Total liability 4,237 67 2,980 55 2,467 50
Total equity 2,090 33 2,420 45 2,499 50

==> picture [720 x 5] intentionally omitted <==

8

Statement

==> picture [53 x 54] intentionally omitted <==

(in NT$M) 2021 Q3 2020 Q3
Beginningcash balance 1,325 1,058
Net income before tax (308) (41)
Depreciation & amortization 142 111
AR (174) 194
Inventory (944) (179)
AP 520 (162)
Others (125) (28)
Operating activities inflow(outflow) (889) (105)
Financial assets at fair value throughprofit or loss (20) 0
Capital expenditure (161) (99)
Investing activities inflow(outflow) (179) (95)
Short term loan 576 (71)
Longterm loan 362 412
Financing activities inflow(outflow) 870 316
Endingcash balance 1,117 1,169

==> picture [720 x 5] intentionally omitted <==

9

==> picture [680 x 70] intentionally omitted <==

Thank You

==> picture [720 x 5] intentionally omitted <==